Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: A pro-apoptosis protein in Escherichia coli

Protein Expression and Purification

Volumn 47, Issue 1, 2006, Pages 36-44

  Ma, Xingyuan ^a   Zheng, Wenyun ^a,b   Wei, Dongzhi ^a   Ma, Yushu ^a   Wang, Tianwen ^a   Wang, Jinzhi ^a   Liu, Qinghai ^a   Yang, Shengli ^a,c  

^a EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Construction; Expression; Pro apoptosis bioactivity; Purification; TAT survivin (T34A) mutant

Indexed keywords

ALANINE; APOPTOSIS REGULATORY PROTEIN; BIRC5 PROTEIN, HUMAN; HYBRID PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; THREONINE; TRANSACTIVATOR PROTEIN; TUMOR PROTEIN;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; ESCHERICHIA COLI; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; POINT MUTATION; PROTEIN RENATURATION; TUMOR CELL LINE;

ALANINE; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL LINE, TUMOR; ESCHERICHIA COLI; GENE PRODUCTS, TAT; HIV; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; POINT MUTATION; PROTEIN RENATURATION; RECOMBINANT FUSION PROTEINS; THREONINE;

ESCHERICHIA COLI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33646086958     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.09.012     Document Type: Article

References (31)

1. Crook N.E., Clem R.J., and Miller L.K. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67 (1993) 2168-2174
2. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3 (1997) 917-921
3. Tamm I., Wang Y., Sausville E., Scudiero D.A., Vigna N., Oltersdorf T., and Reed J.C. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res. 58 (1998) 5315-5320
4. Shin S., Sung B.J., Cho Y.S., Kim H.J., Ha N.C., Hwang J.I., Chung C.W., Jung Y.K., and Oh B.H. An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40 (2001) 1117-1123
5. Ambrosini G., Adida C., Sirugo G., and Altieri D.C. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J. Biol. Chem. 273 (1998) 11177-11182
6. Li F., Ambrosini G., Chu E.Y., Plescia J., Tognin S., Marchisio P.C., and Altieri D.C. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396 (1998) 580-584
7. Krieg A., Mahotka C., Krieg T., Grabsch H., Muller W., Takeno S., Suschek C.V., Heydthausen M., Gabbert H.E., and Gerharz C.D. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br. J. Cancer 86 (2000) 737-743
8. Wurl P., Kappler M., Meye A., Bartel F., Kohler T., Lautenschlager C., Bache M., Schmidt H., and Taubert H. Coexpression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma. Lancet 359 (2002) 943-945
9. Tanaka K., Iwamoto S., Gon G., Nohara T., Iwamoto M., and Tanigawa N. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin. Cancer Res. 6 (2000) 127-134
10. Sarela A.I., Macadam R.C., Farmery S.M., Markham A.F., and Guillou P.J. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46 (2000) 645-650
11. Azuhata T., Scott D., Takamizawa S., Wen J., Davidoff A., Fukuzawa M., and Sandler A. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma. J. Pediatr. Surg. 36 (2001) 1785-1791
12. Chakravarti A., Noll E., Black P.M., Finkelstein D.F., Finkelstein D.M., Dyson N.J., and Loeffler J.S. Quantitatively determined survivin expression levels are of prognostic value in human gliomas. J. Clin. Oncol. 20 (2002) 1063-1068
13. Kobayashi K., Hatano M., Otaki M., Ogasawara T., and Tokuhisa T. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation. Proc. Natl. Acad. Sci. USA 96 (1999) 1457-1462
14. Kasof G.M., and Gomes B.C. Livin, a novel inhibitor-of-apoptosis (IAP) family member. J. Biol. Chem. 276 (2000) 3238-3246
15. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 (2000) 33-42
16. O'Connor D.S., Grossman D., Plescia J., Li F., Zhang H., Villa A., Tognin S., Marchisio P.C., and Altieri D.C. Regulation of apoptosis at cell division by p34cdc2phosphorylation of survivin. Proc. Natl. Acad. Sci. USA 97 (2000) 13103-131037
17. Verdecia M.A., Huang H., Dutil E., Kaiser D.A., Hunter T., and Noel J.P. Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol. 7 (2000) 602-608
18. Grossman D., Kim P.J., Schechner J.S., and Altieri D.C. Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA 98 (2001) 635-640
19. Vives E., Brodin P., and Leblus B. A truncated Tat basic domain rapidly translocates through the plasma membrane and accumulates in the nucleus. J. Biol. Chem. 272 (1997) 16010-16017
20. Nagahara H., Vocero-Akbani A.M., Snyder E.L., Ho A., Latham D.G., Lissy N.A., Becker-Hapak M., Ezhevsky S.A., and Dowdy S.F. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p-27Kip1 induces cell migration. Nat. Med. 4 (1998) 1449-1452
21. Yang Y., Ballatori N., and Smith H.C. Apolipoprotein B mRNA editing and the reduction in synthesis and secretion of the atherogenic risk factor, apolipoprotein B100 can be effectively targeted through TATmediated protein transduction. Mol. Pharmacol. 61 (2002) 269-276
22. Peitz M., Pfannkuche K., Rajewsky K., and Edenhofer F. Ability of the hydrophobic FGF and basic TAT peptides to promote cellular uptake of recombinant Cre recombinase: a tool for efficient genetic engineering of mammalian genomes. Proc. Natl. Acad. Sci. USA 99 (2002) 4489-4494
23. Alblas J., Ulfman L., Hordijk P., and Koenderman L. Activation of RhoA and ROCK are essential for detachment of migrating leukocytes. Mol. Biol. Cell 12 (2001) 2137-2145
24. Vocero-Akbani A.M., Heyden N.V., Lissy N.A., Ratner L., and Dowdy S.F. Killing HIV-infected cells by transduction with an HIV protease activated caspase-3 protein. Nat. Med. 5 (1999) 29-33
25. Alan H., Steven R., Schwarze S., Mermelstein J., Gabriel W., and Steven F.D. Synthetic protein transduction domains: enhanced transduction potential in vitro and in vivo. Cancer Res. 61 (2001) 474-477
26. Sambrook J., and Russell D.W. Molecular Cloning: A Laboratory Manual. 3th edn. (2001), Cold Spring Harbor Laboratory Press, New York
27. Singh N., Sun Y., Nakamura K., Smith M.R., and Colburn N.H. CJUN/AP-1 as possible mediators of tumor necrosis factor-an induced apoptotic response in mouse JB6 tumor cells. Oncol. Res. 7 (1995) 353-362
28. Reddy V.G., Khanna N., and Singh N. Increasing drug sensitivity of cervical carcinoma HeLa cells by stabilizing p53. Biochem. Biophys. Res. Commun. 282 (2001) 409-415
29. Jaattela M. Escaping cell death: survival proteins in cancer. Exp. Cell Res. 248 (1999) 30-43
30. Kawasaki H., Altieri D.C., Lu C.D., Toyoda M., Tenjo T., and Tanigawa N. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58 (1998) 5071-5074
31. Nakagawara A. Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum. Cell 11 (1998) 115-124